WuXi Biologics (Cayman) Inc. (WUXI06)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 4.820 |
|---|---|
| 52-week range | 3.020 – 6.250 |
| Return, 1 month / 3 months | −13.2% / +15.3% |
| Return, 1 year / 3 years | +26.2% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 53.2% |
| Worst drawdown (1 year) | -25.1% |
| Average daily value traded | 0.55M THB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
WuXi Biologics is a contract research, development and manufacturing organisation focused on biologic medicines. The company helps pharmaceutical and biotechnology customers discover, develop and produce antibody-based and other biologic drugs, offering services that span early research through clinical and commercial manufacturing. It is based in China and works with clients around the world, supporting their biologic programmes with process development, testing and production capacity.
The shares are listed on the Thailand Exchange in Thailand under the code WUXI06, and the price on this page is in Thai baht (THB). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
WuXi Biologics (Cayman) Inc. (WUXI06) trades on the Thailand Exchange in Thailand. It last closed at THB 4.820 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 449 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 26.2% and over the last three months it rose 15.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 16.2% | ||
| From 52-week high | -22.9% | ||
| Momentum | 86 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 15.3% | ||
| 6-month return | 33.9% | ||
| 12-month return, skipping the last month | 45.3% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.1% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.55M THB | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.3% |
|---|---|
| 1 month | −13.2% |
| 3 months | +15.3% |
| 6 months | +33.9% |
| 1 year | +26.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.412 / 4.149 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.288 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.